Paloma Partners Management CO Agios Pharmaceuticals, Inc. Transaction History

Paloma Partners Management CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$33.21 - $46.54 $1.37 Million - $1.92 Million	-41,200 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$33.87 - $55.93 $1.4 Million - $2.3 Million	41,200 New	41,200 $1.44 Million
Q2 2019 Aug 14, 2019	SELL	$46.17 - $68.1 $681,700 - $1.01 Million	-14,765 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$45.92 - $67.67 $678,008 - $999,147	14,765 New	14,765 $996,000
Q3 2018 Nov 14, 2018	SELL	$71.67 - $91.95 $528,566 - $678,131	-7,375 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$73.22 - $99.55 $280,066 - $380,778	-3,825 Reduced 34.15%	7,375 $621,000
Q1 2018 May 15, 2018	BUY	$59.83 - $86.53 $670,096 - $969,136	11,200 New	11,200 $916,000
Q4 2017 Feb 14, 2018	SELL	$52.12 - $72.33 $1.07 Million - $1.49 Million	-20,574 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$54.89 - $67.12 $1.13 Million - $1.38 Million	20,574	20,574 $1.37 Million

234

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.95B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.